Microvascular endothelial barrier disruption occurs in a large number of disease states, such as stroke, sepsis, diabetes, hereditary and acquired angioedema, commonly induced by a variety of endogenous inflammatory mediators such as bradykinin [1,2,3,4,5,6]. This evidence concerns the gene KNG1 and acquired angioedema.